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Submitted Sep 27, 2012; accepted Dec 13, 2012.DISCUSSIONDr Carlos E. Donayre (Torrance, Calif). The authors at Ore-
gon Health Sciences report on the vexing problem of surveillance
compliance with different types of aortic pathologies. You heard
from our group that of 586 patients undergoing endovascular
aortic aneurysm repair (EVAR) we only had one post-op
computed tomography (CT) in 56% and only 49% had CTs after
1 year or more.
The authors utilizing the electronic record and using Interna-
tional Classiﬁcation of Diseases, Ninth Revision and current proce-
dural terminology codes as well as their own surgical records
identiﬁed 57 patients undergoing thoracic endovascular aortic
aneurysm repair (TEVAR) (19 of them for blunt aortic injuries),
100 EVAR, 7 with extensions for salvage following EVAR, 7 for
iliac artery aneurysms, and 34 for untreated type B dissection.
Fifty-six percent of patients were lost to follow-up and 11%
did not return for any follow-up imaging following treatment.
Of the 91 who had follow-up, 10 had untreated endoleaks at their
last study, with six of them still alive. In the follow-up group, 14%
had an additional procedure performed with a median interval of
15 months following treatment.
They looked at multiple factors that would affect compliance
as follows: distance, age, marital status, and discharge destination,
but they found them not to be signiﬁcant. Absence of comorbid-
ities was associated with a signiﬁcant lack of compliance. Not
surprising, presence of a complication was associated with longer
duration of follow-up when compared with those without compli-
cations. It is at least reassuring that those lost to follow-up hada signiﬁcantly improved survival compared with the group with
follow-up. Maybe those folks are on to something. I have the
following questions for the authors:
Question 1: Surveillance follow-up is labor intensive and
costly. We employed four full-time nurses who have been with
us for at least 12 years to perform our follow-up. What is the
current protocol at your institution to ensure that patients are
compliant with their follow-up?
Question 2: Patients entered into protocol studies generally
have better compliance with follow-up. How many of your
patients were entered into a protocol study and was there a differ-
ence when they were compared to your non-protocol patients?
Question 3: Of the 34 patients with a type B dissection, 13
required intervention. Since dissections are of special interest to
me, could you expand on the time frame for intervention? Was
rapid expansion of the false lumen or overall thoracic aortic diam-
eter the main reason, or where other factors found?
Question 4: What does your group consider to be ideal
follow-up for EVAR/TEVAR procedures and what would you
suggest to improve compliance with follow-up in our patients?
Dr Marcus R. Kret. Thank you, Dr Donayre. With regard to
your ﬁrst question, patients treated at our institution currently
receive pre- and postoperative counseling stressing the need for
lifelong surveillance. If they fail to present for a scheduled
follow-up visit, a letter is mailed to their home address. In addition,
we make arrangement for some patients to have surveillance
imaging studies performed near their place of residence. These
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vascular surgeons. In the future, we hope to employ a dedicated
nurse coordinator to help maintain recommended follow-up for
patients who require ongoing surveillance. In addition, we will
seek to expand options for local imaging, as well as develop
improved telemedicine networks to facilitate follow-up for patients
who live long distances from our institution. To address your
second question, with few exceptions, patients included in our
study were not part of a research protocol and as such, we did
not compare follow-up between patients who were or were not
part of such a protocol.
For those patients with type B dissection, the average time to
intervention was dependent on the indication for intervention.
There were ﬁve patients who underwent intervention at a median
interval of 20 days because of the presence of a malperfusion
syndrome. Three patients had signs of renal malperfusion, one of
whom also had evidence of mesenteric ischemia. Two others had
claudication symptoms because of distal extension of the dissection
ﬂap. The remaining eight patients underwent intervention for
aneurysm degeneration; these interventions occurred at a median
of 19 months after initial diagnosis.
Finally, with regard to ideal follow-up after EVAR or
TEVAR, our current regimens are surgeon speciﬁc, but imagingis generally performed at 6 months and yearly thereafter. If there
is suspicion of type II endoleak, CT may be performed at 3
months after initial intervention rather than at the typical 6
months. In the sub-group of patients with documented aneurysm
sac shrinkage, and no evidence of endoleak, we are beginning to
utilize ultrasound surveillance. Furthermore, given the inverse
relationship between close follow-up and overall survival in our
study, we plan to pursue further studies in an attempt to identify
patients for whom current surveillance recommendations may be
too aggressive vs those who truly need close follow-up. It remains
a challenge to identify these patients, but factors that seem to put
patients at high risk in prior studies include early endoleak,
evidence of sac expansion, and device utilization outside the
manufacturer’s instructions for use.
In this project, we were unable to clearly identify any patient
factors that could be addressed to help improve follow-up compli-
ance. However, previous studies have suggested that institutional
programs may promote improved surveillance. As such, we
currently have plans to develop an “Aortic Center of Excellence”
with a dedicated nurse/nurse practitioner and support staff who
are capable of coordinating follow-up both at our institution, as
well as locally for patients who are unable to travel for follow-up
visits or surveillance imaging.
